{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Lexington",
      "address_1": "300 Shire Way",
      "reason_for_recall": "Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing",
      "address_2": "",
      "product_quantity": "1,556",
      "code_info": "08569357, exp 4/30/2020;  07983652, 08544833, exp 6/30/2021",
      "center_classification_date": "20191001",
      "distribution_pattern": "Product was distributed throughout the United States.",
      "state": "MA",
      "product_description": "Natpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 pack cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0202-02",
      "report_date": "20191002",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Shire Human Genetic Therapies, Inc.",
      "recall_number": "D-0035-2020",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "83792",
      "termination_date": "20210323",
      "more_code_info": "",
      "recall_initiation_date": "20190912",
      "postal_code": "02421-2101",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}